A Two-Period, Randomized, Open-Label, Crossover Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2016
At a glance
- Drugs Diazepam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Acorda Therapeutics
- 10 Jun 2016 Status changed from active, no longer recruiting to completed.
- 22 Apr 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.
- 22 Apr 2016 Status changed from recruiting to active, no longer recruiting.